Cataract Extraction Clinical Trial
Official title:
Parallel-group Study of Ocular Penetration of Peri-operative Topically Administered Fluoroquinolones With Cataract Surgery
Verified date | September 2017 |
Source | Johns Hopkins University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.
Status | Completed |
Enrollment | 50 |
Est. completion date | November 2009 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Subjects who have a visually significant cataract and are planning to have cataract surgery. - Subjects who are willing/able and have signed informed consent approved by the Institutional Review Board. Exclusion Criteria: - Subjects who have a known hypersensitivity, allergy, or contraindication to any fluoroquinolone medication, in any form. - Subjects who signs of ocular infection or active inflammation in the study eye. - Subjects who have corneal pathology, including epithelial defect, corneal scarring, or severe dry eye syndrome. - Subjects who have used any disallowed medication (including antibiotics) during the time period designated as described in the protocol. - Subjects who have any active or chronic/recurrent ocular or systemic disease that is uncontrolled and is likely to increase the risk of infection to the patient or confound the results of the study. - Subjects who are pregnant (or suspect to be pregnant) or nursing/lactating. - Subjects who have participated in any study of an investigational drug or device within 30 days prior to enrollment. |
Country | Name | City | State |
---|---|---|---|
United States | The Wilmer Eye Institute at Johns Hopkins University | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
Johns Hopkins University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aqueous Humor Concentration of Study Drug | Patients were randomly assigned to receive one drop of either moxifloxacin or besifloxacin every 10 minutes for a total of 4 doses, with the last dose given 30 minutes prior to the time of the cataract incision. The aqueous humor was corrected through the paracentesis site. The specimen was transferred immediately to a polypropylene tube and stored upright at = 20° C. Moxifloxacin and besifloxacin concentrations in the aqueous humor were determined using a validated high performance liquid chromatography (HPLC)-tandem mass spectrometry method. | approximately 3 to 4 months | |
Secondary | Disk Diffusion Assay of Collected Aqueous Humor | A disk diffusion assay was performed to determine the relative antimicrobial activity of the study drug in the aqueous humor. The reference organism used was a clinical isolate of S. epidermidis that will be grown and adjusted to a 0.5 MacFarland turbidity standard. The standardized suspension was inoculated onto a Mueller-Hinton II agar. A sample of the aqueous humor was applied to 6 mm sterile disks, dried, and then placed onto the inoculated Mueller-Hinton II agar plates. The plates were incubated for 24 hours at 35° C. The zone sizes were then recorded. | Approximately 3-4 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00524264 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
Completed |
NCT00521456 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
Completed |
NCT00565695 -
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
|
N/A | |
Completed |
NCT02973880 -
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
|
Phase 3 | |
Completed |
NCT00721695 -
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00466908 -
Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
|
||
Completed |
NCT00366665 -
Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems
|
N/A | |
Completed |
NCT05571683 -
Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
|
||
Not yet recruiting |
NCT04977115 -
Clinical Evaluation of Intraocular Caliper-assisted Capsulotomy for Age-related Cataract
|
N/A | |
Withdrawn |
NCT00366613 -
Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation
|
Phase 4 | |
Completed |
NCT00366496 -
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
|
N/A | |
Not yet recruiting |
NCT03828500 -
Preoperative Fasting for Ambulatory Cataract Surgery: The PRACTICE Study
|
N/A | |
Completed |
NCT00842231 -
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
|
N/A | |
Completed |
NCT00840580 -
Effect on Wound Healing of Vigamox Versus Cravit
|
Phase 4 | |
Completed |
NCT00851760 -
Epiretinal Macular Membrane and Cataract Extraction
|
N/A | |
Recruiting |
NCT03944070 -
Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
|
N/A | |
Completed |
NCT03364972 -
A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
|
N/A | |
Completed |
NCT00824070 -
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
|
Phase 1 | |
Completed |
NCT00366587 -
Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs
|
Phase 4 | |
Completed |
NCT00366691 -
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
|
Phase 4 |